Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Mayinglong Pharmaceutical Group Co Ltd
FDA Inspection
•Mayinglong Pharmaceutical Group Co Ltd•March 14, 2025

FDA Inspection 1264613 - Mayinglong Pharmaceutical Group Co Ltd - March 14, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Mayinglong Pharmaceutical Group Co Ltd, with an inspection on March 14, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company
Mayinglong Pharmaceutical Group Co Ltd
Inspection Date
March 14, 2025
Product Type
Human Drugs
Office
Office of Inspections and Investigations
Open in Dashboard

ID · 1ad73c7c-df72-408e-a5c5-66c29048c1d6

Violation Codes1
21 CFR 211.166(b)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.